Use this link to cite:
http://hdl.handle.net/2183/14682 The Falling Incidence of Hematologic Cancer After Heart Transplantation
Loading...
Identifiers
Publication date
Authors
Delgado Jiménez, Juan Francisco
López, L.
Alonso-Pulpón, Luis
González-Vílchez, Francisco
Almenar-Bonet, Luis
Rábago Juan-Aracil, Gregorio
Pérez-Villa, Félix
Paniagua-Martín, María J.
Arizón, JM
Advisors
Other responsabilities
Journal Title
Bibliographic citation
Crespo-Leiro MG, Delgado-Jiménez J, López L. The falling incidence of hematologic cancer after heart transplantation. Clin Transplant. 2014;28:1142-1147
Type of academic work
Academic degree
Abstract
[Abstract] Background. A number of changes in the management of heart transplantation (HT) patients have each tended to reduce the risk of post-HT hematologic cancer, but little information is available concerning the overall effect on incidence in the HT population.
Methods. Comparison of data from the Spanish Post-Heart-Transplantation Tumour Registry for the periods 1991–2000 and 2001–2010.
Results. The incidence among patients who underwent HT in the latter period was about half that observed in the former, with a particularly marked improvement in regard to incidence more than five yr post-HT.
Conclusions. Changes in HT patient management have jointly reduced the risk of hematologic cancer in the Spanish HT population. Long-term risk appears to have benefited more than short-term risk.
Description
Editor version
Rights
This is the peer reviewed version of the following article which has been published in final form at Wiley Online Library. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for self-archiving